搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
The Lancet
1 小时
The era of GLP-1 receptor agonists: costs versus benefits
Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and acceptably safe for the treatment of type 2 diabetes and obesity, leading to ...
6 小时
on MSN
Can supplements lower blood sugar levels and improve diabetes? Here's what the science says
A range of supplements from cinnamon to chromium claim to improve metabolism and lower blood sugar levels. What's the evidence for them?
8 小时
Protecting Your Kidneys and More: Scientists Identify New Benefits of Semaglutide and Ozempic
GLP-1 agonists substantially slowed kidney deterioration and failure, independent of diabetes status. The most extensive and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
FBI director resigning
Inflation rose in November
Sale of Infowars rejected
Alexander brothers arrested
Man arrested for assault?
Herpes infection study
Sheriff defies new policy
Trump picks ambassadors
Speaks out after acquittal
Dengue spreads in Americas
Suffers minor injuries
Approves security memo
WI kayaker in custody
Agents linked to drug deals
Calls off merger, sues Kroger
The Amazing Kreskin dies
Threatened species proposal
9-time MLB All-Star dies
Retires after 14 seasons
‘The Mod Squad’ actor dies
2024 top search trends
Ohio opioid appeal ruling
GM to stop funding
Suspect's fingerprints match
Attacked judge, sentenced
US starts Nicaragua probe
US loans Ukraine $20B
Macy’s accounting probe
Russia to use new missile?
反馈